192 related articles for article (PubMed ID: 37000405)
1. Vitamin D in hypoparathyroidism: insight into pathophysiology and perspectives in clinical practice.
Cipriani C; Cianferotti L
Endocrine; 2023 Aug; 81(2):216-222. PubMed ID: 37000405
[TBL] [Abstract][Full Text] [Related]
2. Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism.
Bishop CW; Strugnell SA; Csomor P; Kaiser E; Ashfaq A
Am J Nephrol; 2022; 53(6):446-454. PubMed ID: 35551374
[TBL] [Abstract][Full Text] [Related]
3. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial.
Wetmore JB; Kimber C; Mahnken JD; Stubbs JR
Br J Nutr; 2016 Dec; 116(12):2074-2081. PubMed ID: 28065190
[TBL] [Abstract][Full Text] [Related]
4. Native vitamin D in pre-dialysis chronic kidney disease.
Cardoso MP; Pereira LAL
Nefrologia (Engl Ed); 2019; 39(1):18-28. PubMed ID: 30274806
[TBL] [Abstract][Full Text] [Related]
5. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
[TBL] [Abstract][Full Text] [Related]
6. Extended-release calcifediol in stage 3-4 chronic kidney disease: a new therapy for the treatment of secondary hyperparathyroidism associated with hypovitaminosis D.
Cozzolino M; Minghetti P; Navarra P
J Nephrol; 2022 Apr; 35(3):863-873. PubMed ID: 34626363
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D supplementation: cholecalciferol, calcifediol, and calcitriol.
Vieth R
Eur J Clin Nutr; 2020 Nov; 74(11):1493-1497. PubMed ID: 32704098
[TBL] [Abstract][Full Text] [Related]
8. Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol.
Glendenning P; Chew GT; Inderjeeth CA; Taranto M; Fraser WD
Bone; 2013 Oct; 56(2):271-5. PubMed ID: 23792937
[TBL] [Abstract][Full Text] [Related]
9. Cholecalciferol or Calcifediol in the Management of Vitamin D Deficiency.
Sosa Henríquez M; Gómez de Tejada Romero MJ
Nutrients; 2020 May; 12(6):. PubMed ID: 32486496
[TBL] [Abstract][Full Text] [Related]
10. Low-dose cholecalciferol supplementation and dual vitamin D therapy in haemodialysis patients.
Dusilová-Sulková S; Šafránek R; Vávrová J; Horáček J; Pavlíková L; Palička V
Int Urol Nephrol; 2015 Jan; 47(1):169-76. PubMed ID: 25262147
[TBL] [Abstract][Full Text] [Related]
11. Management of hypoparathyroidism: a Position Statement of the Expert Group of the Polish Society of Endocrinology.
Misiorowski W; Dedecjus M; Konstantynowicz J; Zygmunt A; Kos-Kudła B; Lewiński A; Ruchała M; Zgliczyński W
Endokrynol Pol; 2023; 74(5):447-467. PubMed ID: 37902011
[TBL] [Abstract][Full Text] [Related]
12. Is calcifediol better than cholecalciferol for vitamin D supplementation?
Quesada-Gomez JM; Bouillon R
Osteoporos Int; 2018 Aug; 29(8):1697-1711. PubMed ID: 29713796
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria.
Susantitaphong P; Nakwan S; Peerapornratana S; Tiranathanagul K; Katavetin P; Srisawat N; Praditpornsilpa K; Eiam-Ong S
BMC Nephrol; 2017 Jan; 18(1):19. PubMed ID: 28088187
[TBL] [Abstract][Full Text] [Related]
14. Evaluating Vitamin D Repletion Regimens and Effects in Veteran Patients.
Aterrado S; Ono G; Kanehira-Mar S; Meier J; Swislocki A
Ann Pharmacother; 2015 Sep; 49(9):969-77. PubMed ID: 26104054
[TBL] [Abstract][Full Text] [Related]
15. Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol.
Glendenning P; Chew GT; Seymour HM; Gillett MJ; Goldswain PR; Inderjeeth CA; Vasikaran SD; Taranto M; Musk AA; Fraser WD
Bone; 2009 Nov; 45(5):870-5. PubMed ID: 19631774
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D deficiency and its correction in children with sickle cell anaemia.
Wykes C; Arasaretnam A; O'Driscoll S; Farnham L; Moniz C; Rees DC
Ann Hematol; 2014 Dec; 93(12):2051-6. PubMed ID: 24981689
[TBL] [Abstract][Full Text] [Related]
17. Calcifediol: a review of its pharmacological characteristics and clinical use in correcting vitamin D deficiency.
Jodar E; Campusano C; de Jongh RT; Holick MF
Eur J Nutr; 2023 Jun; 62(4):1579-1597. PubMed ID: 36862209
[TBL] [Abstract][Full Text] [Related]
18. Endocrine Complications of Surgical Treatment of Thyroid Cancer: An Update.
Iglesias P; Díez JJ
Exp Clin Endocrinol Diabetes; 2017 Sep; 125(8):497-505. PubMed ID: 28444664
[TBL] [Abstract][Full Text] [Related]
19. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.
Matias PJ; Jorge C; Ferreira C; Borges M; Aires I; Amaral T; Gil C; Cortez J; Ferreira A
Clin J Am Soc Nephrol; 2010 May; 5(5):905-11. PubMed ID: 20203163
[TBL] [Abstract][Full Text] [Related]
20. Calcifediol to treat secondary hyperparathyroidism in patients with chronic kidney disease.
Galassi A; Bellasi A; Ciceri P; Pivari F; Conte F; Cozzolino M
Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1073-1084. PubMed ID: 28846459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
